Manifestations of Diseases / Sequelae (DM, Stroke, COPD, Trauma) — Clinical Documentation Guide (2026)

Code year: FY2026 (Oct 1 2025 – Sep 30 2026)
Audience: Certified Coders, Auditors and Clinical Documentation Specialists
Access: CCO Members
Last updated: April 2026

🔍 Definition

A sequela (plural: sequelae), also historically termed a late effect, is a residual condition or complication that arises as the direct result of a prior disease or injury after the acute phase has ended. Per ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.B.10, "A sequela is the residual effect (condition produced) after the acute phase of an illness or injury has terminated." There is no time limit on when a sequela code may be assigned — the condition may appear soon after the precipitating event or many months to years later.

A manifestation is a clinical sign, symptom, or complication that arises as a direct result of an underlying disease process. In ICD-10-CM, manifestations of diseases are coded using the etiology/manifestation convention: the underlying disease (etiology) is coded first, and the associated manifestation is coded second. The Alphabetic Index signals this pairing by listing manifestation codes in [brackets], meaning the bracketed code cannot be reported as a principal diagnosis.

Key conditions covered in this guide:

  • Diabetes Mellitus (DM): Combination codes (E11.2x–E11.8x) capture DM with specific manifestations (nephropathy, neuropathy, retinopathy, foot ulcer, etc.).
  • Stroke / Cerebrovascular Disease: Sequelae of cerebrovascular disease (I69.x) represent residual neurological deficits after the acute event has resolved.
  • COPD: Combination codes (J44.0, J44.1) capture COPD with acute lower respiratory infection or acute exacerbation, with additional causative organism coded separately.
  • Trauma: 7th character extensions on injury codes (A = initial encounter, D = subsequent encounter, S = sequela) capture the phase of care for traumatic injuries and their late effects.
📝 Coder Note

The terms "manifestation" and "sequela" are related but distinct. A manifestation can occur during the active disease (e.g., diabetic retinopathy in active DM), while a sequela refers specifically to a residual condition after the acute phase has terminated. Both require specific sequencing rules in ICD-10-CM. See CMS ICD-10-CM Guidelines Section I.A.13 (etiology/manifestation) and Section I.B.10 (sequelae).

🗂️ Alternative Terminology

Formal / ICD-10-CM TermColloquial / Lay / Clinical Synonyms
SequelaLate effect, residual effect, aftereffect, long-term consequence, chronic complication
Manifestation of diseaseComplication, secondary condition, disease-related condition, downstream effect
DM with diabetic peripheral neuropathyDiabetic nerve damage, diabetic neuropathy, burning feet from diabetes, peripheral nerve disease in diabetes
DM with diabetic chronic kidney diseaseDiabetic nephropathy, diabetic kidney disease, DM-related CKD
DM with diabetic retinopathyDiabetic eye disease, diabetic macular edema, diabetic blindness
DM with diabetic foot ulcerDiabetic wound, diabetic ulcer, neuropathic ulcer in diabetes
Sequela of cerebral infarction (I69.3xx)Post-stroke deficits, old CVA residuals, chronic stroke effects, post-CVA hemiplegia
COPD with acute lower respiratory infection (J44.0)COPD with pneumonia, COPD with bronchitis, infected COPD
COPD with acute exacerbation (J44.1)COPD flare-up, COPD exacerbation, AECOPD
Traumatic injury, sequela (7th char S)Late effect of injury, post-traumatic residual, old fracture complication, delayed healing
Sequela of burn (T-code with 7th char S)Late effect of burn, burn scar, burn contracture, post-burn deformity
Hypertensive heart failure (I11.0)HTN-related CHF, high blood pressure heart failure

🩺 Signs & Symptoms

The clinical presentation of disease manifestations and sequelae varies significantly by the underlying condition. Coders and CDI specialists should recognize these presentations as potential indicators of codeable conditions:

Diabetic Manifestations

  • Neuropathy: Burning, tingling, or numbness in feet/hands; loss of protective sensation; Charcot foot deformity; autonomic neuropathy (gastroparesis, orthostatic hypotension, neurogenic bladder)
  • Nephropathy: Proteinuria, declining GFR, edema, hypertension; progression to ESRD (CKD stage 5)
  • Retinopathy: Visual blurring, floaters, sudden vision loss, macular edema; nonproliferative vs. proliferative stages
  • Foot ulcer / skin complications: Non-healing wounds, ulcerations of lower extremity, gangrene; deep tissue necrosis
  • Circulatory: Peripheral arterial disease, claudication, absent pedal pulses, rest pain

Stroke Sequelae

  • Hemiplegia or hemiparesis (dominant vs. non-dominant side documentation is critical)
  • Aphasia, dysphasia, dysarthria
  • Dysphagia (swallowing difficulties requiring modified diet or tube feeding)
  • Cognitive deficits, vascular dementia
  • Depression following stroke
  • Monoplegia of upper or lower limb
  • Facial weakness, diplopia, visual field defects
  • Ataxia, coordination difficulties, gait disturbances

COPD Manifestations

  • Chronic productive cough, dyspnea on exertion, wheezing
  • Acute exacerbation: worsening dyspnea, increased sputum production, change in sputum color/character
  • Hypoxemia, hypercapnia requiring supplemental oxygen or mechanical ventilation
  • Cor pulmonale, right heart failure
  • Respiratory failure (Type I or II)
  • Signs of superimposed infection: fever, purulent sputum, consolidation on imaging

Traumatic Sequelae

  • Chronic pain at fracture site or soft tissue injury location
  • Malunion or nonunion of fracture
  • Post-traumatic arthritis
  • Contractures from burn scarring; hypertrophic or keloid scars
  • Chronic traumatic brain injury (TBI) effects: headache, cognitive changes, personality changes
  • Post-traumatic osteomyelitis

🧭 Differential Diagnosis

ConditionKey Distinguishing FeaturesCoding Implication
Sequela of cerebral infarction (I69.3xx)Deficit remains after acute CVA has resolved; no active infarction on imaging; documentation: "history of CVA with residual hemiplegia"Use I69.3xx — NEVER I63.x for old/resolved CVA
Acute cerebral infarction (I63.x)Active, current stroke event; acute imaging findings (DWI positivity); acute treatment ongoingI63.x as principal; add I69.3xx for any pre-existing residual from prior CVA
History of TIA (Z86.73)TIA fully resolved, no residual deficit, no sequelaZ86.73 only — no I69.x
DM Type 1 vs. Type 2 manifestationsE10.x (Type 1) vs. E11.x (Type 2); query provider if type is unclear; presume Type 2 if unspecifiedE11.x for unspecified type per guidelines; never assume Type 1
Neuropathy due to DM vs. idiopathic neuropathyCausal link stated in documentation; DM is present; neuropathy is consistent with known diabetic complicationE11.40 (diabetic neuropathy unspecified) vs. G60.9 (idiopathic); query if unclear link
COPD exacerbation vs. COPD with pneumoniaJ44.1 = exacerbation without identified infection; J44.0 = COPD + lower respiratory infection (add J12-J18 or J20)Critical distinction — J44.0 has different MS-DRG and HCC implications
COPD vs. AsthmaCOPD: typically smokers age 40+, fixed airflow obstruction; Asthma: variable obstruction, atopy history; overlap = asthma-COPD overlap (J44.81)J44.x vs. J45.x vs. J44.81 for overlap
Traumatic injury, initial encounter (7th A) vs. subsequent (7th D) vs. sequela (7th S)A = active treatment; D = healing, routine follow-up; S = residual condition after healing7th character drives payment and HCC; S-coded fractures do not re-trigger HCC
CHF due to HTN (I11.0) vs. CHF unspecified (I50.9)Hypertension + CHF present in same patient; ICD-10-CM assumes causal relationship unless documented otherwiseUse I11.0, not I10 + I50.x separately; add I50.x subcategory for type of CHF
Lupus nephritis (M32.14) vs. CKD unspecified (N18.9)SLE with renal involvement documented; biopsy or clinical diagnosis; always query for specificityM32.14 + N18.x combination; M32.14 carries HCC weight

📋 Clinical Indicators for Coders/CDI

Clinical IndicatorWhat to Look ForAction
Documentation of "late effect," "residual," "due to prior"Provider notes: "residual weakness following CVA," "late effects of traumatic brain injury," "secondary to prior stroke"Assign sequela code (I69.x, T-code with 7th S); code residual condition first, sequela second
DM documented without manifestation specificityE11.9 assigned but chart shows neuropathy consult, nephrology follow-up, foot wound careQuery provider to link DM to manifestation; use combination code; avoid E11.9 if manifestation is present
"Old CVA" or "following old CVA" in documentationH&P mentions "following old CVA" or "history of CVA with residual deficits"Assign I69.3xx (or appropriate I69.x) — NEVER I63.x; document side (dominant/non-dominant)
COPD exacerbation trigger not specifiedAdmit diagnosis: COPD exacerbation; CXR shows infiltrate; cultures pendingIf infection confirmed, use J44.0 + J18.9 (or specific pathogen code); query if chest X-ray shows pneumonia
Trauma patient on "subsequent" visit with complaint of painFollow-up for fracture; patient reports ongoing pain at site; imaging shows incomplete healing7th character D (subsequent) for healing phase; 7th S for true sequela (e.g., malunion, post-traumatic arthritis)
Hypertension + CHF both documentedI10 and I50.x coded separately; combination code missedUse I11.0 (HTN heart disease with CHF) + I50.x subcategory for type; auditors flag separate coding as error
DM + CKD documentedE11.9 + N18.x coded separately; combination code availableUse E11.22 (Type 2 DM with diabetic CKD stage 3); add N18.x for CKD stage; query CKD stage if not documented
Rheumatoid arthritis specificity"Rheumatoid arthritis" documented without seropositivity statusQuery seropositive (M05.x) vs. seronegative (M06.0x) — different HCC implications; seropositive M05.x carries HCC 42
Burn sequela with contractureOld burn site with scar, contracture, or deformity at follow-up visitT-code for burn anatomic site with 7th char S + L90.5 (scar condition) or M24.5x (joint contracture)
⚠️ Common Pitfall

Coders frequently code I63.x (acute cerebral infarction) for patients with an old or resolved stroke. Per ICD-10-CM Official Guidelines Section I.C.9.d, category I63 is reserved for the acute infarction only. Once the acute event has resolved and residual deficits remain, code from category I69.3 (Sequelae of cerebral infarction). Use Z86.73 (Personal history of TIA) only when there are no residual deficits.

🦴 Anatomy & Pathophysiology

Sequelae and Pathophysiologic Mechanisms: Sequelae arise because tissue damage from the primary disease or injury is permanent or only partially reversible. The underlying mechanisms include:

  • Neuronal death (stroke): After ischemic infarction, neurons in the ischemic core die within minutes; the penumbra may recover with reperfusion. Permanent motor, sensory, or cognitive deficits reflect the permanent neuronal loss. Residual hemiplegia, aphasia, or dysphagia are structural sequelae of the irreversible infarct per NCBI StatPearls — Cerebral Infarction.
  • Microvascular disease (DM): Chronic hyperglycemia causes glycation of basement membranes, endothelial dysfunction, and advanced glycation end-products (AGEs), leading to the classic triad of retinopathy, nephropathy, and neuropathy. These manifestations are direct complications of persistent DM and are coded as combination codes in ICD-10-CM per American Diabetes Association — Complications of Diabetes.
  • Airway remodeling (COPD): Chronic inflammation and repeated injury from cigarette smoke, air pollution, and recurrent infections cause irreversible destruction of alveoli (emphysema) and chronic airway inflammation (bronchitis). Exacerbations represent acute decompensation superimposed on chronic remodeling per GOLD Guidelines 2025.
  • Fibrotic repair (burns/trauma): After thermal injury or mechanical trauma, healing proceeds through inflammation, proliferative, and remodeling phases. Hypertrophic scar, keloid, or contracture formation represents disordered extracellular matrix deposition as a late complication of the original injury per NCBI StatPearls — Burn Wound Healing.

Etiology/Manifestation Convention in ICD-10-CM: The Alphabetic Index uses [brackets] to indicate manifestation codes that must always be sequenced second, after the etiology code. The underlying condition (etiology) drives the DRG assignment, HCC weight, and risk adjustment. Manifestation codes identified in brackets are never principal diagnosis on any claim.

💬 CDI Query Trigger

When the chart documents diabetic neuropathy, retinopathy, nephropathy, or peripheral vascular disease and only E11.9 (DM without complications) is coded, initiate a CDI query to link the manifestation to the diabetes. ICD-10-CM combination codes require explicit provider documentation of the causal relationship. Missing this link results in under-capture of HCC risk weight and potential compliance risk.

💊 Medication Impact / Treatment

Medications used for underlying diseases often provide evidence supporting the presence of manifestations and sequelae. Coders and CDI specialists should recognize drug–diagnosis linkages:

Diabetes Manifestations

  • ACE inhibitors / ARBs (lisinopril, losartan): first-line renoprotective agents in diabetic nephropathy — document CKD stage and link to DM (E11.22 + N18.x)
  • Gabapentin / pregabalin / duloxetine: indicate diabetic peripheral neuropathy (E11.40–E11.49)
  • Bevacizumab (Avastin) / anti-VEGF injections: treat diabetic macular edema — link to E11.311/E11.3211 (proliferative or non-proliferative DR with macular edema)
  • Wound care orders / debridement: support diabetic foot ulcer coding (E11.621/E11.622 + L97.x)
  • Insulin use: code Z79.4 (long-term insulin use) for Type 2 DM on insulin per CMS Guidelines Section I.C.4.a.3

Stroke Sequelae

  • Physical therapy, occupational therapy, speech therapy orders: indicate active treatment of sequelae (hemiplegia, aphasia, dysphagia)
  • Anticoagulation (warfarin, DOACs): may be for atrial fibrillation (cause of cardioembolic stroke) or DVT prophylaxis post-stroke; code underlying condition
  • Antispasmodics (baclofen, tizanidine): indicate spasticity as sequela of stroke (I69.398 or I69.343)
  • PEG tube/gastrostomy: supports dysphagia due to sequela (I69.391)

COPD

  • Home oxygen therapy (Z99.81): indicates chronic hypoxemic respiratory failure in setting of COPD
  • Systemic corticosteroids: indicate acute exacerbation (J44.1)
  • Antibiotics: if given for COPD exacerbation with identified respiratory pathogen, supports J44.0 + specific organism code
  • Bronchodilators (LAMA/LABA combinations): maintenance therapy; does not by itself indicate exacerbation
  • Non-invasive positive pressure ventilation (BiPAP): with COPD indicates acute-on-chronic respiratory failure (J96.01); add this code when documented per CMS Guidelines Section I.C.10.a

Trauma Sequelae

  • NSAIDs / opioid pain management: ongoing use at follow-up may indicate persistent pain as sequela (G89.21 post-traumatic chronic pain)
  • Orthopedic hardware, revision surgery: late complication of fracture — use complication of internal fixation device codes (T84.xxx) vs. malunion codes (M84.3x)
  • Compression garments, scar therapy: burn scar management — supports sequela coding (L90.5, T-code with 7th S)

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

Back to All Clinical Documentation Guides

🔒 Register or sign in to read the full guide

Unlock the full guide including:

  • • 📘 ICD-10-CM Guidelines (FY2026)
  • • 🔢 ICD-10-CM Code Set (FY2026)
  • • 🔎 Indexing
  • • 🏥 CPT (2026)
  • • 🧾 HCPCS (2026)
  • • 📚 AHA Coding Clinic (Recent Guidance)
  • • 💰 HCC / Risk Adjustment (v28)
  • • ✍️ CDI Query Templates
  • • 🧑‍⚕️ Treatments (Clinical)
  • • 🎓 Patient Education / Summary

Log in to continue

Photo of author

Laureen Jandroep

Leave a Comment

⚠️ STAGING ENVIRONMENT — staging.cco.us — NOT PRODUCTION ⚠️

Clinical Doc Guides